Clinical experience with the comprehensive use of magnetic stimulation and robotic mechanotherapy in patients with sarcopenia due to motor disorders after stroke

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

A clinical case study evaluates the effectiveness of magnetic stimulation and robotic mechanotherapy in a comprehensive rehabilitation program for a patient with sarcopenia against the background of motor disorders due to stroke. Patient A., 70 years old, with a history of stroke and a clinically and instrumentally confirmed diagnosis of sarcopenia, received a comprehensive rehabilitation method, including a course of magnetic stimulation and robotic mechanotherapy + a basic rehabilitation program (exercise therapy, massage, laser therapy and whirlpool baths). The observation period was 3 months. The effectiveness was assessed using a visual analog pain scale (VAS), functional tests, and a strain gauge method on a robotic treatment and diagnostic complex with biological feedback, on a sensory track.

The results of the rehabilitation course included: a statistically significant reduction in pain syndrome (up to 3 scores on the VAS), an increase in muscle strength, walking speed, and an improvement in the indicators of the rehabilitation diagnosis according to the International Classification of Functioning.

The complex use of magnetic stimulation and robotic mechanotherapy is an effective and safe method of treating patients with sarcopenia due to acute cerebrovascular accident, providing both clinical and morphological recovery.

Full Text

Restricted Access

About the authors

K. D. Kuznetsov

National Medical Research Center for Rehabilitation and Balneology, Ministry of Health of Russia

Author for correspondence.
Email: marchenkovala@nmicrk.ru
ORCID iD: 0009-0002-3299-6984
SPIN-code: 4926-0693
Russian Federation, Moscow

L. A. Marchenkova

National Medical Research Center for Rehabilitation and Balneology, Ministry of Health of Russia

Email: marchenkovala@nmicrk.ru
ORCID iD: 0000-0003-1886-124X
SPIN-code: 9619-8004

Associate Professor, MD

Russian Federation, Moscow

References

  1. Rosenberg I.H. Sarcopenia: origins and clinical relevance. J Nutr. 1997; 127 (5): 990S–991S. doi: 10.1093/jn/127.5.990S
  2. Roubenoff R. Origins and clinical relevance of sarcopenia. Can J Appl Physiol. 2001; 26 (1): 78–89. doi: 10.1139/h01-006
  3. Kilgour R.D., Vigano A., Trutschnigg B., et al. Cancer-related fatigue: the impact of skeletal muscle mass and strength in patients with advanced cancer. J Cachexia Sarcopenia Muscle. 2010; 1 (2): 177–85. doi: 10.1007/s13539-010-0016-0
  4. Schefold J.C., Bierbrauer J., Weber-Carstens S. Intensive care unit - acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shock. J Cachexia Sarcopenia Muscle. 2010; 1 (2): 147–57. doi: 10.1007/s13539-010-0010-6
  5. Martone A.M., Bianchi L., Abete P. et al. The incidence of sarcopenia among hospitalized elderly patients: the results of the study Glisten. J Cachexia Muscle Sarcopenia. 2017; 8: 907–14. doi: 10.1002/jcsm.12224
  6. Sato Y., Yoshimura Y., Abe T. Phase Angle as an Indicator of Baseline Nutritional Status and Sarcopenia in Acute Stroke. J Stroke Cerebrovasc Dis. 2022; 31 (1): 106220. doi: 10.1016/j.jstrokecerebrovasdis.2021.106220
  7. Nozoe M., Kubo H., Kanai M. et al. Reliability and validity of measuring temporal muscle thickness as the evaluation of sarcopenia risk and the relationship with functional outcome in older patients with acute stroke. Clin Neurol Neurosurg. 2021; 201: 106444. doi: 10.1016/j.clineuro.2020.106444
  8. Abe T., Yoshimua Y., Imai R. et al. A Combined Assessment Method of Phase Angle and Skeletal Muscle Index to Better Predict Functional Recovery after Acute Stroke. J Nutr Health Aging. 2022; 26 (5): 445–51. doi: 10.1007/s12603-022-1777-9
  9. Lee H., Lee I.H., Heo J. et al. Impact of Sarcopenia on Functional Outcomes Among Patients with Mild Acute Ischemic Stroke and Transient Ischemic Attack: A Retrospective Study. Front Neurol. 2022; 13: 841945. doi: 10.3389/fneur.2022.841945
  10. Bellelli G., Zambon A., Volpato S. et al. The association between delirium and sarcopenia in older adult patients admitted to acute geriatrics units: Results from the GLISTEN multicenter observational study. Clin Nutr. 2018; 37 (5): 1498–504. doi: 10.1016/j.clnu.2017.08.027
  11. Scherbakov N., Sandek A., Doehner W. Stroke-related sarcopenia: specific characteristics. J Am Med Dir Assoc. 2015; 16 (4): 272–6. doi: 10.1016/j.jamda.2014
  12. Scherbakov N., von Haehling S., Anker S.D. et al. Stroke induced Sarcopenia: muscle wasting and disability after stroke. Int J Cardiol. 2013; 170 (2): 89–94. doi: 10.1016/j.ijcard.2013.10.031
  13. Nishioka S., Yamanuchi A., Matsushita T. et al. Validity of the circumference of the tibia for assessing skeletal muscle mass in patients after stroke. Nutrition. 2021; 82: 111028. doi: 10.1016/j.nut.2020.111028
  14. Кузнецов К.Д., Марченкова Л.А., Стяжкина Е.М. и др. Способ медицинской реабилитации пациентов с саркопенией на фоне последствий острого нарушения мозгового кровообращения. Патент RU 2024113417, 17.05.2024 [Kuznecov K.D., Marchenkova L.A., Styazhkina E.M. et al. Sposob medicinskoj reabilitacii pacientov s sarkopeniej na fone posledstvij ostrogo narusheniya mozgovogo krovoobrashcheniya. Patent RU 2024113417, 17.05.2024 (in Russ.)].

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2025 Russkiy Vrach Publishing House